Envista Holdings Corp (NVST)

USD 16.99

(3.98%)

Net Income Summary of Envista Holdings Corp

  • Envista Holdings Corp's latest annual net income in 2023 was -100.2 Million USD , down -141.22% from previous year.
  • Envista Holdings Corp's latest quarterly net income in 2024 Q3 was 8.2 Million USD , up 100.71% from previous quarter.
  • Envista Holdings Corp reported an annual net income of 243.1 Million USD in 2022, down -7.74% from previous year.
  • Envista Holdings Corp reported an annual net income of 263.5 Million USD in 2021, up 691.29% from previous year.
  • Envista Holdings Corp reported a quarterly net income of -1.15 Billion USD for 2024 Q2, down -4979.66% from previous quarter.
  • Envista Holdings Corp reported a quarterly net income of 8.2 Million USD for 2024 Q3, up 100.71% from previous quarter.

Annual Net Income Chart of Envista Holdings Corp (2023 - 2016)

Historical Annual Net Income of Envista Holdings Corp (2023 - 2016)

Year Net Income Net Income Growth
2023 -100.2 Million USD -141.22%
2022 243.1 Million USD -7.74%
2021 263.5 Million USD 691.29%
2020 33.3 Million USD -84.7%
2019 217.6 Million USD -5.68%
2018 230.7 Million USD -23.38%
2017 301.1 Million USD 10.7%
2016 272 Million USD 0.0%

Peer Net Income Comparison of Envista Holdings Corp

Name Net Income Net Income Difference
Alcon Inc. 974 Million USD 110.287%
AptarGroup, Inc. 284.48 Million USD 135.221%
Baxter International Inc. 2.65 Billion USD 103.773%
Becton, Dickinson and Company 1.72 Billion USD 105.805%
Bausch + Lomb Corporation -260 Million USD 61.462%
Haemonetics Corporation 117.55 Million USD 185.235%
ResMed Inc. 1.02 Billion USD 109.814%
Teleflex Incorporated 356.32 Million USD 128.12%
Warby Parker Inc. -63.19 Million USD -58.552%
West Pharmaceutical Services, Inc. 593.4 Million USD 116.886%